Literature DB >> 9569039

Expression of HGF/SF in mesothelioma cell lines and its effects on cell motility, proliferation and morphology.

P Harvey1, A Warn, S Dobbin, N Arakaki, Y Daikuhara, M C Jaurand, R M Warn.   

Abstract

The expression of hepatocyte growth factor/scatter factor (HGF/SF) was studied in 12 mesothelioma cell lines characterized by either an epithelioid or a fibroblast-like phenotype. Conditioned media from these lines were analysed by bioassay and ELISA, and HGF/SF was detected in three cell lines, all with a fibroblast-like or mixed morphology. None of eight epithelioid cell lines expressed the factor. Thus, for these cell lines, the ability to secrete HGF/SF correlated with the cell phenotype. Following on from these observations, two cell lines, BR and BT, with a fibroblast-like and an epithelioid phenotype, respectively, were further investigated. Both cell lines expressed the Met receptor but only BR secreted HGF/SF. Both cell lines responded to exogenous HGF/SF treatment by a change of morphology but in different ways: BR became more elongated and bipolar, while BT formed more spread-out cell colonies. HGF/SF acted as a paracrine effector on the epithelioid BT cells and stimulated both cell-spreading and proliferation. Interestingly, BT cells spread but did not scatter in response to exogenous HGF/SF. In contrast BR cells showed only some stimulation of cell motility with HGF/SF and no increase in cell proliferation was observed. Because HGF/SF was previously found in the pleural effusion fluids of patients with malignant mesothelioma and in paraffin-embedded tumour tissues, it is concluded that HGF/SF may well stimulate the growth and spread of malignant mesothelioma in vivo by paracrine and/or autocrine mechanisms.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9569039      PMCID: PMC2150119          DOI: 10.1038/bjc.1998.176

Source DB:  PubMed          Journal:  Br J Cancer        ISSN: 0007-0920            Impact factor:   7.640


  48 in total

1.  Immunocytochemical characterization of cell lines from human malignant mesothelioma: characterization of human mesothelioma cell lines by immunocytochemistry with a panel of monoclonal antibodies.

Authors:  L Zeng; J Fleury-Feith; I Monnet; C Boutin; J Bignon; M C Jaurand
Journal:  Hum Pathol       Date:  1994-03       Impact factor: 3.466

2.  Expression of scatter factor in human bladder carcinoma.

Authors:  A Joseph; G H Weiss; L Jin; A Fuchs; S Chowdhury; P O'Shaugnessy; I D Goldberg; E M Rosen
Journal:  J Natl Cancer Inst       Date:  1995-03-01       Impact factor: 13.506

3.  Immunoreactive hepatocyte growth factor is a strong and independent predictor of recurrence and survival in human breast cancer.

Authors:  J Yamashita; M Ogawa; S Yamashita; K Nomura; M Kuramoto; T Saishoji; S Shin
Journal:  Cancer Res       Date:  1994-04-01       Impact factor: 12.701

4.  Continuing increase in mesothelioma mortality in Britain.

Authors:  J Peto; J T Hodgson; F E Matthews; J R Jones
Journal:  Lancet       Date:  1995-03-04       Impact factor: 79.321

5.  Human malignant mesothelial cells: variability of ultrastructural features in established and nude mice transplanted cell lines.

Authors:  J Fleury-Feith; L Kheuang; L Zeng; J Bignon; C Boutin; I Monnet; M C Jaurand
Journal:  J Pathol       Date:  1995-10       Impact factor: 7.996

Review 6.  The role of growth factors and cytokines in the tumorigenesis and immunobiology of malignant mesothelioma.

Authors:  D R Fitzpatrick; D J Peroni; H Bielefeldt-Ohmann
Journal:  Am J Respir Cell Mol Biol       Date:  1995-05       Impact factor: 6.914

7.  Evidence for the presence of an inactive precursor of human hepatocyte growth factor in plasma and sera of patients with liver diseases.

Authors:  N Arakaki; S Kawakami; O Nakamura; T Ohnishi; H Miyazaki; T Ishii; H Tsubouchi; Y Daikuhara
Journal:  Hepatology       Date:  1995-12       Impact factor: 17.425

Review 8.  Scatter factor and the c-met receptor: a paradigm for mesenchymal/epithelial interaction.

Authors:  E M Rosen; S K Nigam; I D Goldberg
Journal:  J Cell Biol       Date:  1994-12       Impact factor: 10.539

9.  Roles of hepatocyte growth factor/scatter factor and the met receptor in the early development of the metanephros.

Authors:  A S Woolf; M Kolatsi-Joannou; P Hardman; E Andermarcher; C Moorby; L G Fine; P S Jat; M D Noble; E Gherardi
Journal:  J Cell Biol       Date:  1995-01       Impact factor: 10.539

10.  Hepatocyte growth factor/scatter factor is present in most pleural effusion fluids from cancer patients.

Authors:  G Eagles; A Warn; R Y Ball; H Baillie-Johnson; N Arakaki; Y Daikuhara; R M Warn
Journal:  Br J Cancer       Date:  1996-02       Impact factor: 7.640

View more
  12 in total

Review 1.  Preclinical studies identify novel targeted pharmacological strategies for treatment of human malignant pleural mesothelioma.

Authors:  Roberto E Favoni; Antonio Daga; Paolo Malatesta; Tullio Florio
Journal:  Br J Pharmacol       Date:  2012-05       Impact factor: 8.739

2.  Pleural mesothelioma instigates tumor-associated fibroblasts to promote progression via a malignant cytokine network.

Authors:  Qi Li; Wei Wang; Tadaaki Yamada; Kunio Matsumoto; Katsuya Sakai; Yoshimi Bando; Hisanori Uehara; Yasuhiko Nishioka; Saburo Sone; Shotaro Iwakiri; Kazumi Itoi; Teruhiro Utsugi; Kazuo Yasumoto; Seiji Yano
Journal:  Am J Pathol       Date:  2011-07-18       Impact factor: 4.307

3.  SV40 replication in human mesothelial cells induces HGF/Met receptor activation: a model for viral-related carcinogenesis of human malignant mesothelioma.

Authors:  P Cacciotti; R Libener; P Betta; F Martini; C Porta; A Procopio; L Strizzi; L Penengo; M Tognon; L Mutti; G Gaudino
Journal:  Proc Natl Acad Sci U S A       Date:  2001-09-25       Impact factor: 11.205

4.  Methionine aminopeptidase-2 regulates human mesothelioma cell survival: role of Bcl-2 expression and telomerase activity.

Authors:  A Catalano; M Romano; I Robuffo; L Strizzi; A Procopio
Journal:  Am J Pathol       Date:  2001-08       Impact factor: 4.307

5.  Inhibition of mesothelioma cancer stem-like cells with adenovirus-mediated NK4 gene therapy.

Authors:  Xu-Bin Deng; Li Xiao; Yue Wu; Fang Jin; Brooke Mossman; Joseph R Testa; Guang-Hui Xiao
Journal:  Int J Cancer       Date:  2014-12-27       Impact factor: 7.396

6.  HGF mediates cell proliferation of human mesothelioma cells through a PI3K/MEK5/Fra-1 pathway.

Authors:  Maria E Ramos-Nino; Steven R Blumen; Tara Sabo-Attwood; Harvey Pass; Michele Carbone; Joseph R Testa; Deborah A Altomare; Brooke T Mossman
Journal:  Am J Respir Cell Mol Biol       Date:  2007-09-13       Impact factor: 6.914

7.  Up-regulation of Bcl-xl by hepatocyte growth factor in human mesothelioma cells involves ETS transcription factors.

Authors:  Xiaobo Cao; James Littlejohn; Charles Rodarte; Lidong Zhang; Benjamin Martino; Philip Rascoe; Kamran Hamid; Daniel Jupiter; W Roy Smythe
Journal:  Am J Pathol       Date:  2009-10-15       Impact factor: 4.307

Review 8.  Pleural mesothelial cells in pleural and lung diseases.

Authors:  Hitesh Batra; Veena B Antony
Journal:  J Thorac Dis       Date:  2015-06       Impact factor: 2.895

Review 9.  Pathogenesis of malignant pleural mesothelioma and the role of environmental and genetic factors.

Authors:  Shoshana J Weiner; Siyamek Neragi-Miandoab
Journal:  J Cancer Res Clin Oncol       Date:  2008-09-12       Impact factor: 4.553

10.  Pathogenesis of malignant pleural mesothelioma and the role of environmental and genetic factors.

Authors:  Shoshana J Weiner; Siyamek Neragi-Miandoab
Journal:  J Carcinog       Date:  2008-07-28
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.